Clinical Trial Update: Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV) [NA]

View source ↗

Summary

A clinical trial evaluating IRay for wet age-related macular degeneration with recurrent leakage due to choroidal neovascularization has been withdrawn; no resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Wet Age-related Macular Degeneration

Drugs mentioned

• IRay

Snippet

Sponsor: Oraya Therapeutics, Inc. | Conditions: Wet Age-related Macular Degeneration, Age-related Macular Degeneration | NA | Status: WITHDRAWN